| 1 |
Croome KP, Lee DD, Keaveny AP, et al. Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors[J]. Transplantation, 2016, 100(12): 2640-2647.
|
| 2 |
Fayek SA, Quintini C, Chavin KD, et al. The Current State of Liver Transplantation in the United States: Perspective From AmericanSociety of Transplant Surgeons (ASTS) Scientific Studies Committee and Endorsed by ASTSCouncil[J]. Am J Transplant, 2016, 6(11): 3093-3104.
|
| 3 |
Lo CM. Expanding living donor liver transplantation[J]. Liver Transpl, 2016, 22(S1): 37-39.
|
| 4 |
De Carlis L, Lauterio A, De Carlis R, et al. Donation After Cardiac Death Liver Transplantation After More Than 20 Minutes of Circulatory Arrest and Normothermic Regional Perfusion[J]. Transplantation, 2016, 100(4): e21-e22.
|
| 5 |
Chapman JR. Organ Transplantation in China[J]. Transplantation, 2015, 99(7): 1312-1313.
|
| 6 |
Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury[J]. Am J Surg, 2001, 181(2): 160-166.
|
| 7 |
Lentsch AB, Kato A, Yoshidome H, et al. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury[J]. Hepatology, 2000, 32(2): 169-173.
|
| 8 |
Zhai Y, Petrowsky H, Hong JC, et al. Ischaemia-reperfusion injury in liver transplantation--from bench to bedside[J]. Nat Rev Gastroenterol Hepatol, 2013, 10(2): 79-89.
|
| 9 |
Zhai Y, Shen XD, O′Connell R, et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway[J]. J Immunol, 2004, 173(12): 7115-7119.
|
| 10 |
Tsung A, Hoffman RA, Izuishi K, et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells[J]. J Immunol, 2005, 175(11): 7661-7668.
|
| 11 |
Liu A, Fang H, Wei W, et al. Ischemic preconditioning protects against liver ischemia/reperfusion injury via heme oxygenase-1-mediated autophagy[J]. Crit Care Med, 2014, 42(12): e762-e771.
|
| 12 |
Kang JW, Cho HI, Lee SM. Melatonin inhibits mTOR-dependent autophagy during liver ischemia/reperfusion[J]. Cell Physiol Biochem, 2014, 33(1): 23-36.
|
| 13 |
Lué A, Solanas E, Baptista P, et al. How important is donor age in liver transplantation?[J]. World J Gastroenterol, 2016, 22(21): 4966-4976.
|
| 14 |
Firl DJ, Hashimoto K, O′Rourke C, et al. Impact of donor age in liver transplantation from donation after circulatory death donors: A decade of experience at Cleveland Clinic[J]. Liver Transpl, 2015, 21(12): 1494-1503.
|
| 15 |
Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index[J]. Am J Transplant, 2006, 6(4): 783-790.
|
| 16 |
Campos-Varela I, Dodge JL, Stock PG, et al. Key donor factors associated with graft loss among liver transplant recipients with human immunodeficiency virus[J]. Clin Transplant, 2016, 30(9): 1140-1145.
|
| 17 |
Li Z, Hu Z, Xiang J, et al. Use of hepatitis B surface antigen-positive grafts in liver transplantation: a matched analysis of the US National database[J]. Liver Transpl, 2014, 20(1): 35-45.
|
| 18 |
Stepanova M, Sayiner M, de Avila L, et al. Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor[J]. BMC Gastroenterol, 2016, 16(1): 137.
|
| 19 |
Olmedilla L, Lisbona CJ, Pérez-Peña JM, et al. Early Measurement of Indocyanine Green Clearance Accurately Predicts Short-Term Outcomes After Liver Transplantation[J]. Transplantation, 2016, 100(3): 613-620.
|
| 20 |
Olmedilla L, Pérez-Peña JM, Ripoll C, et al. Early noninvasive measurement of the indocyanine green plasma disappearance rate accurately predicts early graft dysfunction and mortality after deceased donor liver transplantation[J]. Liver Transpl, 2009, 15(10): 1247-1253.
|
| 21 |
Blok JJ, Detry O, Putter H, et al. Longterm results of liver transplantation from donation after circulatory death[J]. Liver Transpl, 2016, 22(8): 1107-1114.
|
| 22 |
Mathur AK, Heimbach J, Steffick DE, et al. Donation after cardiac death liver transplantation: predictors of outcome[J]. Am J Transplant, 2010, 10(11): 2512-2519.
|
| 23 |
Reich DJ, Mulligan DC, Abt PL, et al. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation[J]. Am J Transplant, 2009, 9(9): 2004-2011.
|
| 24 |
van der Plaats A, ′t Hart NA, Morariu AM, et al. Effect of University of Wisconsin organ-preservation solution on haemorheology[J]. Transpl Int, 2004, 17(5): 227-233.
|
| 25 |
Dutkowski P, Polak WG, Muiesan P, et al. First Comparison of Hypothermic Oxygenated PErfusion Versus Static Cold Storage of Human Donation After Cardiac Death Liver Transplants: An International-matched Case Analysis[J]. Ann Surg, 2015, 262(5): 764-770; discussion 770-771.
|
| 26 |
Nassar A, Liu Q, Farias K, et al. Impact of Temperature on Porcine Liver Machine Perfusion From Donors After Cardiac Death[J]. Artif Organs, 2016, 40(10): 999-1008.
|
| 27 |
Zhang ZB, Gao W, Shi Y, et al. Protective role of normothermic machine perfusion during reduced-size liver transplantation inpigs[J]. Liver Transpl, 2016, 22(7): 968-978.
|
| 28 |
Liu Q, Nassar A, Farias K, et al. Sanguineous normothermic machine perfusion improves hemodynamics and biliary epithelial regeneration in donation after cardiac death porcine livers[J]. Liver Transpl, 2014, 20(8): 987-999.
|
| 29 |
Perera T, Mergental H, Stephenson B, et al. First human liver transplantation using a marginal allograft resuscitated by normothermic machine perfusion[J]. Liver Transpl, 2016, 22(1): 120-124.
|
| 30 |
Verhoeven CJ, Farid WR, de Jonge J, et al. Biomarkers to assess graft quality during conventional and machine preservation in liver transplantation[J]. J Hepatol, 2014, 61(3): 672-684.
|
| 31 |
Ravikumar R, Jassem W, Mergental H, et al. Liver Transplantation After Ex Vivo Normothermic Machine Preservation: A Phase 1 (First-in-Man) Clinical Trial[J]. Am J Transplant, 2016, 16(6): 1779-1787.
|
| 32 |
Vogel T, Brockmann JG, Quaglia A, et al. The 24-hour normothermic machine perfusion of discarded human liver grafts[J]. Liver Transpl, 2017, 23(2): 207-220.
|
| 33 |
Bral M, Gala-Lopez B, Bigam D, et al. Preliminary Single-Center Canadian Experience of Human Normothermic Ex Vivo Liver Perfusion: Results of a Clinical Trial[J]. Am J Transplant, 2017, 17(4): 1071-1080.
|
| 34 |
Gringeri E, Bonsignore P, Bassi D, et al. Subnormothermic machine perfusion for non-heart-beating donor liver grafts preservation in a Swine model: a new strategy to increase the donor pool?[J]. Transplant Proc, 2012, 44(7): 2026-2028.
|
| 35 |
Berendsen TA, Bruinsma BG, Lee J, et al. A simplified subnormothermic machine perfusion system restores ischemically damaged liver grafts in a rat model of orthotopic liver transplantation[J]. Transplant Res, 2012, 1(1): 6.
|
| 36 |
Olschewski P, Gass P, Ariyakhagorn V, et al. The influence of storage temperature during machine perfusion on preservation quality of marginal donor livers[J]. Cryobiology, 2010, 60(3): 337-343.
|
| 37 |
Furukori M, Matsuno N, Meng LT, et al. Subnormothermic Machine Perfusion Preservation With Rewarming for Donation After Cardiac Death Liver Grafts in Pigs[J]. Transplant Proc, 2016, 48(4): 1239-1243.
|
| 38 |
Bruinsma BG, Yeh H, Ozer S, et al. Subnormothermic machine perfusion for ex vivo preservation and recovery of the human liver for transplantation[J]. Am J Transplant, 2014, 14(6): 1400-1409.
|
| 39 |
de Rougemont O, Breitenstein S, Leskosek B, et al. One hour hypothermic oxygenated perfusion (HOPE) protects nonviable liver allografts donated after cardiac death[J]. Ann Surg, 2009, 250(5): 674-683.
|
| 40 |
Schlegel A, Kron P, Graf R, et al. Warm vs. cold perfusion techniques to rescue rodent liver grafts[J]. J Hepatol, 2014, 61(6): 1267-1275.
|
| 41 |
Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation in human liver transplantation: the first clinical series[J]. Am J Transplant, 2010, 10(2): 372-381.
|
| 42 |
Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation facilitates successful transplantation of ″orphan″ extended criteria donor livers[J]. Am J Transplant, 2015, 15(1): 161-169.
|
| 43 |
Westerkamp AC, Karimian N, Matton AP, et al. Oxygenated Hypothermic Machine Perfusion After Static Cold Storage Improves Hepatobiliary Function of Extended Criteria Donor Livers[J]. Transplantation, 2016, 100(4): 825-835.
|
| 44 |
Monbaliu D, Heedfeld V, Liu Q, et al. Hypothermic machine perfusion of the liver: is it more complex than for the kidney?[J]. Transplant Proc, 2011, 43(9): 3445-3450.
|
| 45 |
Fondevila C, Hessheimer AJ, Maathuis MH, et al. Hypothermic oxygenated machine perfusion in porcine donation after circulatory determination of death liver transplant[J]. Transplantation, 2012, 94(1): 22-29.
|
| 46 |
Schlegel A, Kron P, Dutkowski P. Hypothermic machine perfusion in liver transplantation[J]. Curr Opin Organ Transplant, 2016, 21(3): 308-314.
|
| 47 |
Fukazawa K, Lang JD. Role of nitric oxide in liver transplantation: Should it be routinely used?[J]. World J Hepatol, 2016, 8(34): 1489-1496.
|
| 48 |
Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics[J]. Nat Rev Drug Discov, 2008, 7(2): 156-167.
|
| 49 |
Wood KC, Gladwin MT. The hydrogen highway to reperfusion therapy[J]. Nat Med, 2007, 13(6): 673-674.
|
| 50 |
Zhang CB, Tang YC, Xu XJ, et al. Hydrogen gas inhalation protects against liver ischemia/reperfusion injury by activating the NF-κB signaling pathway[J]. Exp Ther Med, 2015, 9(6): 2114-2120.
|
| 51 |
Lee LY, Kaizu T, Toyokawa H, et al. Carbon monoxide induces hypothermia tolerance in Kupffer cells and attenuates liver ischemia/reperfusion injury in rats[J]. Liver Transpl, 2011, 17(12): 1457-1466.
|
| 52 |
Younis NN, Shaheen MA, Mahmoud MF. Silymarin preconditioning protected insulin resistant rats from liver ischemia-reperfusion injury:role of endogenous H2S[J]. J Surg Res, 2016, 204(2): 398-409.
|
| 53 |
Björnsson B, Bojmar L, Olsson H, et al. Nitrite, a novel method to decrease ischemia/reperfusion injury in the rat liver[J]. World J Gastroenterol, 2015, 21(6): 1775-1783.
|
| 54 |
Rocha-Santos V, Figueira ER, Rocha-Filho JA, et al. Pentoxifylline enhances the protective effects of hypertonic saline solution on liver ischemia reperfusion injury through inhibition of oxidative stress[J]. Hepatobiliary Pancreat Dis Int, 2015, 14(2): 194-200.
|
| 55 |
Figueira ER, Bacchella T, Coelho AM, et al. Timing-dependent protection of hypertonic saline solution administration in experimental liver ischemia/reperfusion injury[J]. Surgery, 2010, 147(3): 415-423.
|
| 56 |
von Frankenberg M, Golling M, Mehrabi A, et al. Donor pretreatment with gadolinium chloride improves early graft function and survival after porcine liver transplantation[J]. Transpl Int, 2003, 16(11): 806-813.
|
| 57 |
Luntz SP, Unnebrink K, Seibert-Grafe M, et al. HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312][J]. BMC Surg, 2005, 5: 18.
|
| 58 |
Kotsch K, Ulrich F, Reutzel-Selke A, et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial[J]. Ann Surg, 2008, 248(6): 1042-1050.
|
| 59 |
Bedirli N, Ofluoglu E, Kerem M, et al. Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model[J]. Anesth Analg, 2008, 106(3): 830-837.
|
| 60 |
Pirenne J, Monbaliu D, Aerts R, et al. Biliary strictures after liver transplantation: risk factors and prevention by donor treatment with epoprostenol[J]. Transplant Proc, 2009, 41(8): 3399-3402.
|
| 61 |
Nagrath D, Xu H, Tanimura Y, et al. Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo[J]. Metab Eng, 2009, 11(4-5): 274-283.
|
| 62 |
Kong R, Gao Y, Sun B, et al. The strategy of combined ischemia preconditioning and salvianolic acid-B pretreatment to prevent hepatic ischemia-reperfusion injury in rats[J]. Dig Dis Sci, 2009, 54(12): 2568-2576.
|
| 63 |
D′Amico F, Vitale A, Piovan D, et al. Use of N-acetylcysteine during liver procurement: a prospective randomized controlled study[J]. Liver Transpl, 2013, 19(2): 135-144.
|
| 64 |
Pratschke S, Eder M, Heise M, et al. Protocol TOP-Study (tacrolimus organ perfusion): a prospective randomized multicenter trial toreduce ischemia reperfusion injury in transplantation of marginal liver grafts with an ex vivo tacrolimus perfusion[J]. Transplant Res, 2013, 2(1): 3.
|
| 65 |
Zhai Y, Busuttil RW, Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation[J]. Am J Transplant, 2011, 11(8): 1563-1569.
|
| 66 |
Verhoeven CJ, Farid WR, de Jonge J, et al. Biomarkers to assess graft quality during conventional and machine preservation in liver transplantation[J]. J Hepatol, 2014, 61(3): 672-684.
|
| 67 |
Sun P, Zhang P, Wang PX, et al. Mindin deficiency protects the liver against ischemia/reperfusion injury[J]. J Hepatol, 2015, 63(5): 1198-1211.
|
| 68 |
Zhang B, Liu QH, Zhou CJ, et al. Protective effect of eNOS overexpression against ischemia/reperfusion injury in small-for-size liver transplantation[J]. Exp Ther Med, 2016, 12(5): 3181-3188.
|
| 69 |
Nemes B, Gámán G, Polak WG, et al. Extended criteria donors in liver transplantation Part I: reviewing the impact of determining factors[J]. Expert Rev Gastroenterol Hepatol, 2016, 10(7): 827-839.
|
| 70 |
Sibulesky L, Li M, Hansen RN, et al. Impact of Cold Ischemia Time on Outcomes of Liver Transplantation: A Single Center Experience[J]. Ann Transplant, 2016, 21: 145-151.
|